Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Maureen Okam Achebe, MD, MPH
Healthcare Provider Clinical Director
Non-Malignant Hematology Clinic
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, Massachusetts, United States
Dr. Maureen M. Okam studied medicine at University of Port Harcourt Medical School (1995). Her interests are hematologic disorders, anemia, sickle cell disease and thalassemia, thrombosis and anticoagulant therapy, thrombocytopenia, myelodysplasia and myeloproliferative disorders.
Her current research focuses on the pre-clinical and clinical development of new agents for the treatment of hemoglobinopathies – sickle cell disease and thalassemia. Her on-going clinical evaluation of histone deacetylase inhibitors in the induction of fetal hemoglobin, is funded by the National Institutes of Health through a Harvard Blood Scholars research grant.
Appointments:
Clinical Director, Non-Malignant Hematology Clinic
Assistant Director, Brigham and Women’s Hospital Outpatient Infusion Center
Director, Brigham and Women’s Hospital Sickle Cell Program
Assistant Professor in Medicine, Harvard Medical School
Related Content
-
Wally Smith, MDWally Smith is Professor of Internal Med...
-
John T. Horan MD, MPHJohn T. Horan, MD, MPH, is Associate Pro...
-
The Comprehensive Sickle Cell Center at Children’s Hospital of PhiladelphiaThe Comprehensive Sickle Cell Center at ...
-
The Association Between Timely Opioid Administration and Hospitalization in Children With Sickle Cell Disease Presen...Objective: To evaluate the association ...
-
A Patient Advocate’s Take on Sickle Cell Disease: The Pain and the PromiseSeptember is National Sickle Cell Awaren...
-
Howard University Hospital Center for Sickle Cell DiseaseTransitioning from pediatric to adult pr...
-
A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)Limited evidence guides opioid dosing st...
+myBinder